Email this article Protective role of silver nanoparticles in influenza infection
- Authors: Al Farroukh M.1,2, Skomorokhova E.A.1, Magazenkova D.N.3, Kiseleva I.V.1,2
-
Affiliations:
- Institute of Experimental Medicine
- Saint Petersburg State University
- ITMO University
- Issue: Vol 21, No 3 (2021)
- Pages: 81-84
- Section: Conference proceedings
- URL: https://journals.rcsi.science/MAJ/article/view/76290
- DOI: https://doi.org/10.17816/MAJ76290
- ID: 76290
Cite item
Open Access
Access granted
Subscription Access
Abstract
BACKGROUND: The present study assesses copper metabolism of the host organism as a target of antiviral strategy, basing on the “virocell” concept. This concept suggests that the targets for suppressing viral reproduction can be found in the host’s metabolism.
AIM: Evaluation of the effect of copper status indicators on influenza infection in mice.
MATERIALS AND METHODS: Silver nanoparticles (AgNPs) were used as a specific active agent because they reduce the level of holo-ceruloplasmin, the main extracellular cuproenzyme. The mouse model of influenza virus A infection was used with two doses: 1 LD50 and 10 LD50. The following treatment regimens were used: mice were pretreated four days before infection and then every day during infection development until the end of the experiment (day 14).
RESULTS: The mice treated with AgNPs demonstrated significantly lower mortality, the protection index reached 60–70% at the end of the experiment, and mean lifespan was prolonged. In addition, the treatment of the animals with AgNPs resulted in normalization of the weight dynamics. Despite the amelioration of the infection, AgNPs treatment did not influence influenza virus replication.
CONCLUSIONS: This study provides support for the view that silver nanoparticles could be used as protection against influenza.
Full Text
##article.viewOnOriginalSite##About the authors
Mohammad Al Farroukh
Institute of Experimental Medicine; Saint Petersburg State University
Author for correspondence.
Email: mouhammad1farroukh@gmail.com
ORCID iD: 0000-0003-0017-4126
SPIN-code: 5075-2110
Postgraduate student
Russian Federation, Saint PetersburgEkaterina A. Skomorokhova
Institute of Experimental Medicine
Email: katjaskom@yandex.ru
ORCID iD: 0000-0001-6018-2190
SPIN-code: 1544-0664
PhD (Biol.), Researcher
Russian Federation, Saint PetersburgDaria N. Magazenkova
ITMO University
Email: magdash@mail.ru
ORCID iD: 0000-0003-1959-7110
SPIN-code: 4882-6260
engineer
Russian Federation, Saint PetersburgIrina V. Kiseleva
Institute of Experimental Medicine; Saint Petersburg State University
Email: irina.v.kiseleva@mail.ru
ORCID iD: 0000-0002-3892-9873
SPIN-code: 7857-7306
Dr. Sci. (Biol.), Professor, Laboratory Head
Russian Federation, Saint PetersburgReferences
- Up to 650 000 people die of respiratory diseases linked to seasonal flu each year [Internet]. WHO. 2017. Available from: http://www.who.int/mediacentre/news/releases/2017/seasonal-flu/en/. Accessed: June 2, 2021.
- Forterre P. The virocell concept and environmental microbiology. ISME J. 2013;7(2):233–236. doi: 10.1038/ismej.2012.110
- Xiang D, Duan W, Shigdar S, et al. Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo. International Journal of Nanomedicine. 2013;8:4103–4113. doi: 10.2147/ijn.S53622
- Xiang DX, Chen Q, Pang, L, Zheng, CL. Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro. J Virol Methods. 2011;178(1–2):137–142. doi: 10.1016/j.jviromet.2011.09.003
- Mehrbod P, Motamed N, Tabatabaian M, et al. In vitro antiviral effect of “nanosilver” on influenza virus. DARU Journal of Pharmaceutical Sciences. 2009;17(2):88–93.
Supplementary files
